AU1791301A - N-alkylated peptides having antiangiogenic activity - Google Patents

N-alkylated peptides having antiangiogenic activity

Info

Publication number
AU1791301A
AU1791301A AU17913/01A AU1791301A AU1791301A AU 1791301 A AU1791301 A AU 1791301A AU 17913/01 A AU17913/01 A AU 17913/01A AU 1791301 A AU1791301 A AU 1791301A AU 1791301 A AU1791301 A AU 1791301A
Authority
AU
Australia
Prior art keywords
antiangiogenic activity
alkylated peptides
alkylated
peptides
antiangiogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17913/01A
Inventor
Michael F. Bradley
Fortuna Haviv
Jack Henkin
Douglas M. Kalvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU1791301A publication Critical patent/AU1791301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU17913/01A 1999-11-22 2000-11-22 N-alkylated peptides having antiangiogenic activity Abandoned AU1791301A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44709999A 1999-11-22 1999-11-22
US09447099 1999-11-22
US70264900A 2000-10-31 2000-10-31
US09702649 2000-10-31
PCT/US2000/032105 WO2001038397A1 (en) 1999-11-22 2000-11-22 N-alkylated peptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
AU1791301A true AU1791301A (en) 2001-06-04

Family

ID=27034850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17913/01A Abandoned AU1791301A (en) 1999-11-22 2000-11-22 N-alkylated peptides having antiangiogenic activity

Country Status (10)

Country Link
EP (1) EP1242455A1 (en)
JP (1) JP2003514920A (en)
AR (1) AR026901A1 (en)
AU (1) AU1791301A (en)
BR (1) BR0010934A (en)
CA (1) CA2386893A1 (en)
CO (1) CO5261544A1 (en)
HK (1) HK1050902A1 (en)
MX (1) MXPA02005139A (en)
WO (1) WO2001038397A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
JP5167473B2 (en) 2005-03-03 2013-03-21 コヴェックス・テクノロジーズ・アイルランド・リミテッド Anti-angiogenic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0890101A4 (en) * 1996-03-05 1999-12-08 Torrey Pines Inst Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein
AU724077B2 (en) * 1996-05-03 2000-09-14 Abbvie Inc. Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
DE69827223T2 (en) * 1997-03-17 2006-02-02 Northwestern University, Chicago ANTIANGIOGENIC SUBSTANCE FOR THE TREATMENT OF CANCER, ARTHRITIS AND NETWORK GLAND DISEASES

Also Published As

Publication number Publication date
WO2001038397A1 (en) 2001-05-31
EP1242455A1 (en) 2002-09-25
AR026901A1 (en) 2003-03-05
CA2386893A1 (en) 2001-05-31
BR0010934A (en) 2002-12-17
CO5261544A1 (en) 2003-03-31
JP2003514920A (en) 2003-04-22
MXPA02005139A (en) 2004-08-23
HK1050902A1 (en) 2003-07-11

Similar Documents

Publication Publication Date Title
GB2351912B (en) Defibrillation system
GB9912852D0 (en) Peptides
AU1791301A (en) N-alkylated peptides having antiangiogenic activity
AU5545500A (en) Improved welding system
HK1120294A1 (en) Electrode
EP1181031A4 (en) Novel antiangiogenic peptides
PL368745A1 (en) Peptides having antiangiogenic activity
GB9901321D0 (en) Bead assembly
AU4547300A (en) Polypeptides derived from endostatin exhibiting antiangiogenic activity
EP1147130A4 (en) Alpha-conotoxin peptides
EP1159288A4 (en) Alpha-conotoxin peptides
GB0120713D0 (en) Peptides
AU5549400A (en) Catalysts
AU2109200A (en) Polypeptide
GB9908795D0 (en) Distributed mode speakers
AU6637700A (en) Tryptase-like polypeptide ztryp1
EP1151100A4 (en) Tau-conotoxin peptides
GB2388323B (en) Defibrillation system
AU2002315383A1 (en) Peptides having antiangiogenic activity
GB9918680D0 (en) Polypeptide
AUPQ387399A0 (en) Peptides
AUPQ305799A0 (en) Peptides
AU3821400A (en) Overall
GB9928325D0 (en) Peptides
GB9907911D0 (en) Peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase